Trend in approval of targeted biologics in the last two decades
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
Egile nagusia: | Siddika, Khadiza |
---|---|
Beste egile batzuk: | Ahmed, Syeda Maliha |
Formatua: | Thesis |
Hizkuntza: | English |
Argitaratua: |
Brac University
2024
|
Gaiak: | |
Sarrera elektronikoa: | http://hdl.handle.net/10361/24296 |
Antzeko izenburuak
-
Targeted therapeutic options in the treatment of Breast Cancer
nork: Alam, Kazi Tasnuva
Argitaratua: (2022) -
Study on anticancer drugs approved by the FDA from 2014 to 2023
nork: Rattry, Faria Rahman
Argitaratua: (2024) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
nork: Tania, Umme
Argitaratua: (2023) -
RIPK pathway, as a potential target, for cancer treatment - a review
nork: Jahan, Nusrat
Argitaratua: (2024) -
Molecular biology : genes to proteins /
nork: Tropp, Burton E.
Argitaratua: (2008)